close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Canopy Growth Corporation - Common Shares (NQ:CGC)

0.8828 +0.0074 (+0.85%)
Delayed Quote Updated: 3:25 PM EDT, Oct 5, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Canopy Growth Corporation - Common Shares

< Previous 1 2 3 4 5 6 7 8 9
...
89 90 Next >
News headline image
Canopy Growth Is Closing in on Positive EBITDA. Should You Buy the Stock? ↗
Improving fundamentals are making Canopy harder to ignore. 
Via The Motley Fool
Topics Cannabis
News headline image
Canopy Growth Appoints Sebastian Blöte as Country Manager for Germany
From Canopy Growth Corporation
Via Business Wire
News headline image
Canopy Growth Announces Adjournment of 2026 Annual General and Special Meeting Due to Lack of Quorum
From Canopy Growth Corporation
Via Business Wire
News headline image
Canopy Growth Is Eyeing Another Reverse Stock Split. Will It Be Enough to Light a Fire Beneath the Beaten-Down Pot Stock? ↗
Canopy Growth's stock has continued to fall, prompting the company to proactively seek to retain access to capital markets. 
Via The Motley Fool
Topics Bonds Cannabis
News headline image
Canopy Growth Announces Extension of Proxy Voting Deadline for 2026 Annual General and Special Meeting
From Canopy Growth Corporation
Via Business Wire
News headline image
Canopy Growth Expands European Medical Cannabis Supply Into the UK
From Canopy Growth Corporation
Via Business Wire
News headline image
Canopy Growth's Business Is Improving. So Why Isn't the Stock Performing Better? ↗
Two long-standing issues continue to weigh on this cannabis stock. 
Via The Motley Fool
Topics Cannabis
News headline image
Canopy Growth Reminds Shareholders to Vote Ahead of September 23 Deadline
From Canopy Growth Corporation
Via Business Wire
News headline image
Canopy Growth Broadens Australian Medical Cannabis Portfolio With New Formats and Formulations
From Canopy Growth Corporation
Via Business Wire
News headline image
Canopy Growth's Revenue Grew 13% Last Quarter. Investors Barely Reacted. Here's Why. ↗
Revenue is growing, but the cannabis company still has a lot to prove to investors. 
Via The Motley Fool
Topics Cannabis
News headline image
Should You Buy Canopy Growth Stock on the Rebound? ↗
Canopy Growth benefited from growth across all its divisions in the first quarter of fiscal 2027, but does that make it a worthwhile investment? 
Via The Motley Fool
Topics Cannabis
News headline image
Better Cannabis Stock to Buy Right Now: Canopy Growth or Tilray Brands? ↗
The Canadian cannabis companies are both seeing strong growth, but one is a better buy right now. 
Via The Motley Fool
Topics Cannabis
News headline image
Curaleaf's Hostile Takeover Bid for Aurora Is Just the Tip of the Iceberg for Cannabis Consolidation. These 2 Stocks Could Be the Biggest Winners. ↗
After a huge gold rush, the marijuana sector stumbled, and now consolidation is gaining momentum. 
Via The Motley Fool
Topics Cannabis
News headline image
Canopy Growth Announces Mailing of Proxy Materials for 2026 Annual General and Special Meeting – Urges Shareholders to Vote Now
From Canopy Growth Corporation
Via Business Wire
News headline image
Curaleaf Wants to Buy Aurora Cannabis for $272 Million. Is Canopy Growth the Next Marijuana Takeover Target? ↗
Cannabis consolidation appears to be accelerating. 
Via The Motley Fool
Topics Cannabis
News headline image
Canopy Growth (CGC) Q1 2027 Earnings Call Transcript ↗
Revenue grew 13% as MTL integration and Polish market strength drove results. 
Via The Motley Fool
Topics Cannabis Earnings World Trade
News headline image
Canopy Growth Secures Renewed EU GMP Certification at Kincardine as European Medical Cannabis Business Grows
From Canopy Growth Corporation
Via Business Wire
News headline image
Will Canopy Growth Get Acquired? ↗
Curaleaf is attempting to acquire Canopy Growth's rival, Aurora Cannabis, and there could be more consolidation to come in the industry. 
Via The Motley Fool
Topics Cannabis
News headline image
Canopy Growth Targets European Cannabis Expansion After MTL Deal and Cost Cuts ↗
Canopy Growth (NASDAQ:CGC) is positioning itself for further expansion in medical cannabis, European markets and Canadian recreational cannabis after restructuring operations, reducing costs and... 
Via MarketBeat
Topics Cannabis Economy
News headline image
Canopy Growth: Penny Stock Purgatory -- or Cannabis Rebound in the Making? ↗
The turnaround is becoming more believable. 
Via The Motley Fool
Topics Cannabis
News headline image
Why Rescheduling Might Not Move Canopy Growth's Stock as Much as You Think ↗
Canopy Growth is a marijuana stock, but U.S. regulations aren't the main driver of its business. 
Via The Motley Fool
Topics Cannabis
News headline image
Canopy Growth Q1 Earnings Call Highlights ↗
Canopy Growth (NASDAQ:CGC) reported first-quarter fiscal 2027 net revenue of C$81.2 million, up 13% from the prior-year period, as the company recorded year-over-year growth across its cannabis and... 
Via MarketBeat
Topics Cannabis Earnings
News headline image
Canopy Growth Reports First Quarter Fiscal Year 2027 Financial Results; Delivers 13% Net Revenue Growth with Contributions from All Businesses
From Canopy Growth Corporation
Via Business Wire
News headline image
Thinking About Buying Canopy Growth? You May Want to Wait for This 1 Thing to Happen First. ↗
The next key catalyst for this cannabis stock lies in the hands of a U.S. Federal Government agency. 
Via The Motley Fool
Topics Cannabis Economy Government
News headline image
Canopy Growth to Report First Quarter Fiscal 2027 Financial Results on August 7, 2026
From Canopy Growth Corporation
Via Business Wire
News headline image
Canopy Growth Announces Participation at Upcoming Canaccord Genuity Growth Conference
From Canopy Growth Corporation
Via Business Wire
News headline image
President Trump's Major Marijuana Move: What It Means for Canopy Growth, Green Thumb, and Tilray ↗
The president directed federal authorities to reschedule medical marijuana. 
Via The Motley Fool
Topics Cannabis Government
News headline image
Is Canopy Growth Stock Finally Worth Buying After Losing 99% of Its Value? ↗
A lower stock price doesn't eliminate investment risk. 
Via The Motley Fool
Topics Cannabis
News headline image
Canopy Growth: Is Another Reverse Stock Split Inevitable? ↗
Shares of the cannabis company have fallen below the $1 mark again. 
Via The Motley Fool
Topics Cannabis
News headline image
Could Canopy Growth Stock Deliver a 4X Gain? 1 Analyst Thinks So. ↗
Be careful before bucking the bearish trend. 
Via The Motley Fool
Topics Cannabis
< Previous 1 2 3 4 5 6 7 8 9
...
89 90 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at /week.